pemigatinib 13.5 MG Oral Tablet
Managing this medication for someone you care for? Eleplan keeps diagnoses, medications and appointments in one plan.
Start free with EleplanClinical drug
pemigatinib 13.5 MG Oral Tablet
13.5 MG · Oral Tablet · oral
A form of pemigatinib →
pemigatinib 13.5 MG Oral Tablet — Fibroblast growth factor receptor (FGFR) tyrosine kinase inhibitors. Strength, form, class, interactions & more.
Active ingredient
Classification
Fibroblast growth factor receptor (FGFR) tyrosine kinase inhibitorsKinase Inhibitor
Drug interactions
Pemigatinib has significant interactions with CYP3A inducers and inhibitors.
- majorstrong and moderate CYP3A inducers — decreases pemigatinib plasma concentrations, which may reduce efficacy
- majorstrong and moderate CYP3A inhibitors — increases pemigatinib plasma concentrations, which may increase the incidence and severity of adverse reactions
Source: RxNorm + openFDA + RxClass + FAERS · 2026
Look up another medication